CA3078630A1 - Periodontitis vaccine and related compositions and method of use - Google Patents
Periodontitis vaccine and related compositions and method of use Download PDFInfo
- Publication number
- CA3078630A1 CA3078630A1 CA3078630A CA3078630A CA3078630A1 CA 3078630 A1 CA3078630 A1 CA 3078630A1 CA 3078630 A CA3078630 A CA 3078630A CA 3078630 A CA3078630 A CA 3078630A CA 3078630 A1 CA3078630 A1 CA 3078630A1
- Authority
- CA
- Canada
- Prior art keywords
- sequence
- amino acid
- acid sequence
- seq
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571582P | 2017-10-12 | 2017-10-12 | |
| US62/571,582 | 2017-10-12 | ||
| PCT/US2018/055496 WO2019075260A1 (en) | 2017-10-12 | 2018-10-11 | VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3078630A1 true CA3078630A1 (en) | 2019-04-18 |
Family
ID=64110091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3078630A Pending CA3078630A1 (en) | 2017-10-12 | 2018-10-11 | Periodontitis vaccine and related compositions and method of use |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10835590B2 (https=) |
| EP (1) | EP3694547A1 (https=) |
| JP (2) | JP7258870B2 (https=) |
| KR (2) | KR20230066660A (https=) |
| CN (1) | CN111225684A (https=) |
| AU (1) | AU2018347511A1 (https=) |
| CA (1) | CA3078630A1 (https=) |
| EA (1) | EA202090908A1 (https=) |
| IL (1) | IL273690A (https=) |
| MA (1) | MA50363A (https=) |
| MX (1) | MX2020003810A (https=) |
| PH (1) | PH12020550239A1 (https=) |
| SG (1) | SG11202003147XA (https=) |
| WO (1) | WO2019075260A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202003147XA (en) * | 2017-10-12 | 2020-05-28 | Vaxcyte Inc | Periodontitis vaccine and related compositions and method of use |
| WO2025019900A1 (en) * | 2023-07-26 | 2025-01-30 | Denteric Pty Ltd | Chimeric protein vaccine |
| CN116751292B (zh) * | 2023-07-31 | 2024-05-14 | 河南大学 | 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59128338A (ja) | 1982-12-08 | 1984-07-24 | Kitasato Inst:The | 歯周炎予防用ワクチン及びその製法 |
| WO1994028014A2 (en) | 1993-05-28 | 1994-12-08 | Chiron Corporation | Peptide inhibitors of urokinase receptor activity |
| AUPN627595A0 (en) * | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| CA2249994A1 (en) * | 1996-03-22 | 1997-09-25 | University Of Georgia Research Foundation, Inc. | Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| US6833262B1 (en) | 1999-04-21 | 2004-12-21 | University Of Georgia Research Foundation, Inc. | Polypeptide having amidolytic activity for a serpin |
| AUPQ065299A0 (en) | 1999-05-28 | 1999-06-24 | University Of Sydney, The | A method of prophylaxis and treatment and agents useful for same |
| AUPQ485999A0 (en) * | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US7378101B2 (en) | 2001-12-21 | 2008-05-27 | Pfizer, Inc. | Vaccine for periodontal disease |
| GB0411150D0 (en) | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| CN102712693A (zh) | 2009-08-02 | 2012-10-03 | 圣诺菲·帕斯图尔有限公司 | 牙龈卟啉单胞菌多肽 |
| WO2011097688A1 (en) | 2010-02-12 | 2011-08-18 | The University Of Sydney | Protein domains and uses therefor |
| US9040253B2 (en) | 2010-04-14 | 2015-05-26 | Sutro Biopharma, Inc. | Method for enhancing recombinant protein production by cell-free protein expression system |
| PL2906592T3 (pl) | 2012-10-12 | 2019-07-31 | Sutro Biopharma, Inc. | Proteolityczna inaktywacja wybranych białek w ekstraktach bakteryjnych dla ulepszonej ekspresji |
| EP3365027B1 (en) * | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| SG11202003147XA (en) | 2017-10-12 | 2020-05-28 | Vaxcyte Inc | Periodontitis vaccine and related compositions and method of use |
-
2018
- 2018-10-11 SG SG11202003147XA patent/SG11202003147XA/en unknown
- 2018-10-11 MX MX2020003810A patent/MX2020003810A/es unknown
- 2018-10-11 EA EA202090908A patent/EA202090908A1/ru unknown
- 2018-10-11 AU AU2018347511A patent/AU2018347511A1/en not_active Abandoned
- 2018-10-11 US US16/158,155 patent/US10835590B2/en active Active
- 2018-10-11 MA MA050363A patent/MA50363A/fr unknown
- 2018-10-11 CA CA3078630A patent/CA3078630A1/en active Pending
- 2018-10-11 EP EP18797289.8A patent/EP3694547A1/en active Pending
- 2018-10-11 JP JP2020520602A patent/JP7258870B2/ja active Active
- 2018-10-11 KR KR1020237015301A patent/KR20230066660A/ko not_active Ceased
- 2018-10-11 KR KR1020207013299A patent/KR102530966B1/ko active Active
- 2018-10-11 WO PCT/US2018/055496 patent/WO2019075260A1/en not_active Ceased
- 2018-10-11 CN CN201880065401.1A patent/CN111225684A/zh active Pending
-
2020
- 2020-03-29 IL IL273690A patent/IL273690A/en unknown
- 2020-04-08 PH PH12020550239A patent/PH12020550239A1/en unknown
-
2021
- 2021-05-05 US US17/308,872 patent/US11701414B2/en active Active
-
2023
- 2023-04-05 JP JP2023061241A patent/JP2023098935A/ja active Pending
- 2023-05-30 US US18/325,563 patent/US12121575B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20240226259A9 (en) | 2024-07-11 |
| US20210361756A1 (en) | 2021-11-25 |
| US20190192645A1 (en) | 2019-06-27 |
| US10835590B2 (en) | 2020-11-17 |
| PH12020550239A1 (en) | 2021-02-15 |
| US12121575B2 (en) | 2024-10-22 |
| BR112020006500A2 (pt) | 2020-10-13 |
| KR20230066660A (ko) | 2023-05-16 |
| US11701414B2 (en) | 2023-07-18 |
| AU2018347511A1 (en) | 2020-05-21 |
| US20240131134A1 (en) | 2024-04-25 |
| JP2020536925A (ja) | 2020-12-17 |
| SG11202003147XA (en) | 2020-05-28 |
| WO2019075260A1 (en) | 2019-04-18 |
| KR20200070302A (ko) | 2020-06-17 |
| CN111225684A (zh) | 2020-06-02 |
| MX2020003810A (es) | 2020-08-13 |
| JP2023098935A (ja) | 2023-07-11 |
| EA202090908A1 (ru) | 2020-10-29 |
| MA50363A (fr) | 2020-08-19 |
| AU2018347511A8 (en) | 2020-06-11 |
| KR102530966B1 (ko) | 2023-05-15 |
| JP7258870B2 (ja) | 2023-04-17 |
| IL273690A (en) | 2020-05-31 |
| EP3694547A1 (en) | 2020-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12121575B2 (en) | Periodontitis vaccine and related compositions and methods of use | |
| JP7847091B2 (ja) | 肺炎桿菌ｏ抗原ワクチン | |
| KR100517114B1 (ko) | 폴리감마글루탐산을 함유하는 면역보강제 조성물 | |
| CN102203121A (zh) | 牙龈卟啉单胞菌感染的预防、治疗和诊断 | |
| JP2017513849A (ja) | Ａ群レンサ球菌ワクチン | |
| AU2009323682A1 (en) | Glutamyl tRNA synthetase (GtS) fragments | |
| US9119803B2 (en) | Carious tooth vaccine and preparation method | |
| US12280097B2 (en) | Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of use | |
| EP4466013A1 (en) | Chimeric polypeptides | |
| US10933126B2 (en) | Clostridium difficile immunogenic compositions and methods of use | |
| EA044863B1 (ru) | Вакцина и связанные композиции для лечения пародонтита и способ применения | |
| BR112020006500B1 (pt) | Composição imunogênica e seus usos, formulação de vacina e usos de um polipeptídeo para fabricação de uma composição imunogênica | |
| FR2809960A1 (fr) | Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante | |
| EP0420743A1 (fr) | Vaccin protecteur contre l'hémophilose porcine | |
| EA050190B1 (ru) | Оптимизированный бесклеточный синтез плазмидного антигена инвазии в и родственные композиции и способы применения | |
| WO2011033319A1 (en) | Commensal neisserial stress protein preparations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20231004 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241010 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241010 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20241210 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20250410 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250929 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250929 |